Drag

Bliss GVS Pharma

Healthcare NSE:BLISSGVS

203.60INR
20.40 ( 11.14%)

Last update at Feb. 9, 2026, midnight

Day Range

183.50205.80
LowHigh

52 Week Range

107.78 195.80
LowHigh

Fundamentals

  • Previous Close 183.20
  • Market Cap 17701.13M
  • Volume9,078,679
  • P/E Ratio 16.64
  • EBITDA 1190.20M
  • Revenue TTM 8602.72M
  • Revenue Per Share TTM 81.65
  • Gross Profit TTM 4198.78M
  • Diluted EPS TTM 10.06

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Past Performance

Status Stocks Entry Price Entry Date Exit Date Duration Duration Type Sector *Return(%)
CLOSED BLISSGVS ₹ 161.21 18/12/25 18/12/25 Same Day Short Term Healthcare 2.23%

Financials

Income Statement

Total Revenue
Net Income

Balance Sheet

Total Assets
Total Liabilities

Change in Cash

Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Income before tax 1256.39M 1168.72M 1060.72M 541.65M 1041.27M
Net income 842.99M 754.54M 708.59M 150.40M 684.91M
Total Revenue 8097.26M 7659.08M 7474.29M 7379.29M 5686.88M
Gross Profit 3960.38M 2494.30M 3502.63M 3469.47M 2397.79M
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Total assets 13008.39M 12138.68M 11568.53M 11087.47M 10767.86M
Intangible assets 2.30M 1.07M 2.29M 3.83M 5.79M
Other current assets 1121.31M 1480.08M 952.62M 705.22M 401.99M
Deferred long term liab - - - - -
Non current assets other - - - - -
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Change in Cash 2.26M -14.16M 30.20M 88.53M -22.05M
Operating Cash 1059.13M 1524.49M 343.14M 1354.81M 639.69M
Free Cash Flow 298.48M 1241.19M -594.86M 614.78M 548.45M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change Price Market Cap (M) P/E Ratio
NSE:BLISSGVS
Bliss GVS Pharma 		20.40 11.14% 203.60 17701.13 16.64
SUNPHARMA
Sun Pharmaceutical Industries Limited 		11.20 0.66% 1706.30 4224508.76 40.32
DIVISLAB
Divi's Laboratories Limited 		85.50 1.42% 6110.00 1752225.28 70.47
TORNTPHARM
Torrent Pharmaceuticals Limited 		57.60 1.46% 3996.60 1362716.66 63.48
CIPLA
Cipla Limited 		12.20 0.92% 1342.20 1183505.97 21.74

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data ("EODHD") on an 'as is' basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.